Krutika Patel
Family · Washington, DCNPI 1821597634
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations.
Across 98 payments — averaging $21.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$292
- Novo Nordisk$284
- Amgen$280
- AbbVie$257
- Astellas Pharma US Inc$188
- Lilly USA, LLC$155
- plus $681 from 17 others
What the payments were for
- Food & beverage$2,07197%
- Education$663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 14 | $292 |
| Novo Nordisk | 13 | $284 |
| Amgen | 13 | $280 |
| AbbVie | 12 | $257 |
| Astellas Pharma US Inc | 6 | $188 |
| Lilly USA, LLC | 8 | $155 |
| Merck | 6 | $149 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $75 |
| Exact Sciences | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| AstraZeneca | 4 | $49 |
| Boehringer Ingelheim | 2 | $46 |
| E.r. Squibb & Sons, L.L.C. | 1 | $29 |
| TMS Neurohealth Centers Inc. | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Idorsia Pharmaceuticals US Inc | 2 | $26 |
| Seqirus USA Inc | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Abbott | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $12 |
How this compares
$2,137 in reported general payments places this provider in the 85th percentile of 392 family providers in District of Columbia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 14 | $11,970 |
| Rosuvastatin Calcium | 46 | $981 |
| Metoprolol Succinate | 32 | $706 |
| Atorvastatin Calcium | 47 | $558 |
| Levothyroxine Sodium | 44 | $492 |
| Losartan Potassium | 41 | $484 |
| Simvastatin | 13 | $365 |
| Olmesartan Medoxomil | 13 | $275 |
| Tamsulosin Hcl | 11 | $231 |
| Pantoprazole Sodium | 21 | $221 |
| Lisinopril | 23 | $215 |
| Famotidine | 11 | $195 |
| Metformin Hcl | 25 | $171 |
| Amlodipine Besylate | 38 | $169 |
| Trazodone Hcl | 21 | $168 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $149 | $11,97014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 392 family providers in District of Columbia.
Other family in Washington
- Amy StewartWashington$489K
- Kara CouchWashington$144K
- Laura XandersWashington$109K
- Laura MackeWashington$39K
- Cassandra ThompsonWashington$11K
- Sharmin DiazWashington$9K
- Emily BertrandWashington$8K
- Ana Carrion-GelabertWashington$7K
- Chanda CopelandWashington$7K
- Suad NsouliWashington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.